These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 3344851)

  • 41. Diagnosis of cerebrotendinous xanthomatosis (CTX) and effect of chenodeoxycholic acid therapy by analysis of urine using capillary gas chromatography.
    Wolthers BG; Volmer M; van der Molen J; Koopman BJ; de Jager AE; Waterreus RJ
    Clin Chim Acta; 1983 Jun; 131(1-2):53-65. PubMed ID: 6883710
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effect of LDL-apheresis on a case of Cerebrotendinous Xanthomatosis].
    Fukuo Y; Hayama N; Hara K; Terashi A; Seta K
    Rinsho Shinkeigaku; 1989 Feb; 29(2):196-201. PubMed ID: 2752648
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cerebrotendinous xanthomatosis.
    Bel S; García-Patos V; Rodríguez L; Selva A; Díaz P; Wolthers BG; Castells A
    J Am Acad Dermatol; 2001 Aug; 45(2):292-5. PubMed ID: 11464194
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cerebrotendinous xanthomatosis: clinical and biochemical evaluation of eight patients and review of the literature.
    Kuriyama M; Fujiyama J; Yoshidome H; Takenaga S; Matsumuro K; Kasama T; Fukuda K; Kuramoto T; Hoshita T; Seyama Y
    J Neurol Sci; 1991 Apr; 102(2):225-32. PubMed ID: 2072121
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cerebrotendinous xanthomatosis, a treatable metabolic disorder].
    Heller R; Grau AJ; Schäbitz WR; Schwaninger M
    Nervenarzt; 2002 Dec; 73(12):1160-6. PubMed ID: 12486565
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel frameshift mutation in the sterol 27-hydroxylase gene in an Egyptian family with cerebrotendinous xanthomatosis without cataract.
    Abdel-Hamid MS; Issa MY; Otaify GA; Zaki MS
    Metab Brain Dis; 2017 Apr; 32(2):311-315. PubMed ID: 28229379
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Capillary gas chromatographic determination of cholestanol/cholesterol ratio in biological fluids. Its potential usefulness for the follow-up of some liver diseases and its lack of specificity in diagnosing CTX (cerebrotendinous xanthomatosis).
    Koopman BJ; van der Molen JC; Wolthers BG; de Jager AE; Waterreus RJ; Gips CH
    Clin Chim Acta; 1984 Mar; 137(3):305-15. PubMed ID: 6421514
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of cerebrotendinous xanthomatosis with low-density lipoprotein (LDL)-apheresis.
    Mimura Y; Kuriyama M; Tokimura Y; Fujiyama J; Osame M; Takesako K; Tanaka N
    J Neurol Sci; 1993 Feb; 114(2):227-30. PubMed ID: 8445406
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hydrophilic 7 beta-hydroxy bile acids, lovastatin, and cholestyramine are ineffective in the treatment of cerebrotendinous xanthomatosis.
    Batta AK; Salen G; Tint GS
    Metabolism; 2004 May; 53(5):556-62. PubMed ID: 15131757
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epileptic seizure as a presenting symptom of cerebrotendinous xanthomatosis.
    Arlazoroff A; Roitberg B; Werber E; Shidlo R; Berginer VM
    Epilepsia; 1991; 32(5):657-61. PubMed ID: 1915172
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Magnetic resonance imaging of the brain and spinal cord in cerebrotendinous xanthomatosis.
    Bencze KS; Vande Polder DR; Prockop LD
    J Neurol Neurosurg Psychiatry; 1990 Feb; 53(2):166-7. PubMed ID: 2107278
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Cerebrotendinous xanthomatosis and phytosterolemia].
    Nakamura T; Matsuzawa Y
    Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):794-7. PubMed ID: 3152095
    [No Abstract]   [Full Text] [Related]  

  • 53. [Pathophysiology of cerebrotendinous xanthomatosis].
    Koyama S; Kato T
    Rinsho Shinkeigaku; 2016 Dec; 56(12):821-826. PubMed ID: 27840382
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Isolation of 5 alpha-cholestane-3 beta, 7 alpha-diol from bile of patients with cerebrotendinous xanthomatosis. Inefficiency of this steroid as a precursor to cholestanol.
    Björkhem I; Buchmann MS; Skrede S
    Biochim Biophys Acta; 1983 Sep; 753(2):220-6. PubMed ID: 6412759
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cerebrotendinous xanthomatosis as a multisystem disease mimicking premature ageing.
    Dotti MT; Salen G; Federico A
    Dev Neurosci; 1991; 13(4-5):371-6. PubMed ID: 1817044
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Isotopomer spectral analysis of intermediates of cholesterol synthesis in patients with cerebrotendinous xanthomatosis.
    Clarenbach JJ; Lindenthal B; Dotti MT; Federico A; Kelleher JK; von Bergmann K
    Metabolism; 2005 Mar; 54(3):335-44. PubMed ID: 15736111
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An unusual cause of Achilles tendon xanthoma.
    Parente F; Vesnaver M; Massie R; Baass A
    J Clin Lipidol; 2016; 10(4):1040-1044. PubMed ID: 27578138
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cerebrotendinous xanthomatosis: A cause of cataracts and tendon xanthoma.
    Swartz M; Burman KD; Salen G
    Am J Med Sci; 1982; 283(3):147-52. PubMed ID: 6805326
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cerebrotendinous xanthomatosis associated with immune thrombocytopenia.
    El Husseiny NM
    BMJ Case Rep; 2010 Nov; 2010():. PubMed ID: 22791847
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A novel pathway for biosynthesis of cholestanol with 7 alpha-hydroxylated C27-steroids as intermediates, and its importance for the accumulation of cholestanol in cerebrotendinous xanthomatosis.
    Skrede S; Björkhem I; Buchmann MS; Hopen G; Fausa O
    J Clin Invest; 1985 Feb; 75(2):448-55. PubMed ID: 3919058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.